Logo image of HEPS

D-MARKET ELECTRONIC SERV-ADR (HEPS) Stock Fundamental Analysis

NASDAQ:HEPS - Nasdaq - US23292B1044 - ADR - Currency: USD

2.66  -0.17 (-6.01%)

After market: 2.66 0 (0%)

Fundamental Rating

3

Overall HEPS gets a fundamental rating of 3 out of 10. We evaluated HEPS against 31 industry peers in the Broadline Retail industry. While HEPS seems to be doing ok healthwise, there are quite some concerns on its profitability. HEPS is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

HEPS had negative earnings in the past year.
HEPS had a positive operating cash flow in the past year.
HEPS had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: HEPS reported negative operating cash flow in multiple years.
HEPS Yearly Net Income VS EBIT VS OCF VS FCFHEPS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 2B -2B 4B

1.2 Ratios

With a Return On Assets value of -6.54%, HEPS is not doing good in the industry: 64.52% of the companies in the same industry are doing better.
HEPS's Return On Equity of -43.66% is on the low side compared to the rest of the industry. HEPS is outperformed by 70.97% of its industry peers.
Industry RankSector Rank
ROA -6.54%
ROE -43.66%
ROIC N/A
ROA(3y)-11.34%
ROA(5y)-14.4%
ROE(3y)-45.04%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HEPS Yearly ROA, ROE, ROICHEPS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 50 -50

1.3 Margins

HEPS has a worse Gross Margin (35.27%) than 64.52% of its industry peers.
In the last couple of years the Gross Margin of HEPS has grown nicely.
The Profit Margin and Operating Margin are not available for HEPS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 35.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.14%
GM growth 5Y6.31%
HEPS Yearly Profit, Operating, Gross MarginsHEPS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 10 -10 20 -20 30

5

2. Health

2.1 Basic Checks

HEPS does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for HEPS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HEPS Yearly Shares OutstandingHEPS Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 100M 200M 300M
HEPS Yearly Total Debt VS Total AssetsHEPS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 5B 10B 15B 20B

2.2 Solvency

An Altman-Z score of 2.65 indicates that HEPS is not a great score, but indicates only limited risk for bankruptcy at the moment.
HEPS has a better Altman-Z score (2.65) than 64.52% of its industry peers.
HEPS has a debt to FCF ratio of 0.35. This is a very positive value and a sign of high solvency as it would only need 0.35 years to pay back of all of its debts.
HEPS has a better Debt to FCF ratio (0.35) than 90.32% of its industry peers.
A Debt/Equity ratio of 0.44 indicates that HEPS is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.44, HEPS is in line with its industry, outperforming 41.94% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 0.35
Altman-Z 2.65
ROIC/WACCN/A
WACC30.59%
HEPS Yearly LT Debt VS Equity VS FCFHEPS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 1B 2B 3B 4B

2.3 Liquidity

HEPS has a Current Ratio of 1.02. This is a normal value and indicates that HEPS is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of HEPS (1.02) is worse than 87.10% of its industry peers.
A Quick Ratio of 0.66 indicates that HEPS may have some problems paying its short term obligations.
HEPS's Quick ratio of 0.66 is on the low side compared to the rest of the industry. HEPS is outperformed by 77.42% of its industry peers.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 0.66
HEPS Yearly Current Assets VS Current LiabilitesHEPS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 5B 10B 15B

3

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%62.92%

3.2 Future

HEPS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 72.45% yearly.
The Revenue is expected to grow by 31.39% on average over the next years. This is a very strong growth
EPS Next Y161.33%
EPS Next 2Y72.45%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year37.58%
Revenue Next 2Y31.39%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

HEPS Yearly Revenue VS EstimatesHEPS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 20B 40B 60B 80B
HEPS Yearly EPS VS EstimatesHEPS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 2 -2 4 -4 -6

4

4. Valuation

4.1 Price/Earnings Ratio

HEPS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 33.50, the valuation of HEPS can be described as expensive.
Based on the Price/Forward Earnings ratio, HEPS is valued a bit more expensive than 61.29% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of HEPS to the average of the S&P500 Index (22.20), we can say HEPS is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 33.5
HEPS Price Earnings VS Forward Price EarningsHEPS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HEPS is on the same level as its industry peers.
HEPS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. HEPS is cheaper than 80.65% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.86
EV/EBITDA 20.19
HEPS Per share dataHEPS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

HEPS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as HEPS's earnings are expected to grow with 72.45% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y72.45%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for HEPS!.
Industry RankSector Rank
Dividend Yield N/A

D-MARKET ELECTRONIC SERV-ADR

NASDAQ:HEPS (5/27/2025, 8:00:01 PM)

After market: 2.66 0 (0%)

2.66

-0.17 (-6.01%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)04-30 2025-04-30/bmo
Earnings (Next)06-13 2025-06-13
Inst Owners14.19%
Inst Owner Change25.11%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap867.16M
Analysts82.22
Price Target4.23 (59.02%)
Short Float %2.35%
Short Ratio2.53
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 33.5
P/S 0.54
P/FCF 6.86
P/OCF 5.08
P/B 9.2
P/tB 36.84
EV/EBITDA 20.19
EPS(TTM)-0.13
EYN/A
EPS(NY)0.08
Fwd EY2.99%
FCF(TTM)0.39
FCFY14.57%
OCF(TTM)0.52
OCFY19.67%
SpS4.95
BVpS0.29
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.54%
ROE -43.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 35.27%
FCFM 7.82%
ROA(3y)-11.34%
ROA(5y)-14.4%
ROE(3y)-45.04%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.14%
GM growth 5Y6.31%
F-Score4
Asset Turnover2.57
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 0.35
Debt/EBITDA 1
Cap/Depr 94.74%
Cap/Sales 2.74%
Interest Coverage N/A
Cash Conversion 413.77%
Profit Quality N/A
Current Ratio 1.02
Quick Ratio 0.66
Altman-Z 2.65
F-Score4
WACC30.59%
ROIC/WACCN/A
Cap/Depr(3y)121.47%
Cap/Depr(5y)110.53%
Cap/Sales(3y)3.7%
Cap/Sales(5y)2.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y161.33%
EPS Next 2Y72.45%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%62.92%
Revenue Next Year37.58%
Revenue Next 2Y31.39%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y79.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year252.1%
EBIT Next 3Y95.44%
EBIT Next 5YN/A
FCF growth 1Y411.4%
FCF growth 3Y124.57%
FCF growth 5Y100.63%
OCF growth 1Y855.4%
OCF growth 3Y124.87%
OCF growth 5Y97.22%